Pyxis Oncology Cash Flow Statement (2020-2025) | PYXS

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-35.73M-5.93M-11.62M-16.42M-31.38M-25.56M-27.67M-36.10M-19.89M-16.46M-23.65M-16.17M-5.34M-17.30M-21.20M-35.57M-21.67M-18.07M-22.00M-18.12M
Share-based Compensation (Quarter)
2.45M0.55M0.31M3.11M3.40M2.82M3.16M6.44M4.88M3.67M5.18M3.21M4.32M2.87M2.98M2.77M3.63M3.02M3.07M2.08M
Gains from Sales and Divestitures (Quarter)
0.33M0.31M0.10M0.20M
Gains from Investment Securities (Quarter)
3.53M5.93M0.34M0.04M0.72M14.30M5.71M100.000.10M-0.05M6.89M1.28M-0.06M12.23M0.70M12.58M0.90M
Non-cash Items (Quarter)
34.76M16.41M1.20M1.34M1.54M0.07M5.28M2.66M3.43M0.14M3.18M3.29M5.27M0.04M4.38M0.50M5.13M0.59M
Cash from Operations (Quarter)
-18.73M2.86M-7.29M-12.17M-27.68M-23.71M-20.56M-17.39M-26.84M-11.03M-17.58M-15.25M-20.71M-3.01M-14.66M-19.29M-22.54M-17.26M-13.28M-10.43M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.61M1.26M1.48M1.44M1.29M1.64M1.65M1.53M1.16M0.90M0.53M0.38M
Depreciation & Amortization (CF) (Quarter)
0.11M0.22M0.16M0.16M0.16M0.16M0.20M0.19M0.19M0.52M0.52M0.69M1.12M0.58M0.73M0.55M0.55M0.54M0.53M2.90M
Change in Working Capital
Change in Receivables (Quarter)
8.00M
Change in Account Payables (Quarter)
-0.45M0.08M0.97M4.03M-9.90M5.76M-2.31M-1.89M-0.75M-1.56M-1.54M0.35M-1.36M3.18M-0.60M-0.01M-2.01M6.57M0.34M1.13M
Change in Accured Expenses (Quarter)
-0.49M0.38M3.28M1.93M10.54M-10.04M5.13M6.32M-13.27M2.13M0.71M-3.66M-2.14M-0.81M3.97M-2.69M-1.31M-3.36M1.30M0.55M
Other Working Capital Changes (Quarter)
-0.15M-0.15M1.14M-1.45M0.23M0.03M0.41M2.81M1.33M0.08M0.31M-5.23M0.18M0.20M0.28M-0.34M0.33M0.53M-0.38M
Investing Activities
Capital Expenditures (Quarter)
0.17M0.37M0.15M0.13M1.08M3.12M4.41M2.26M0.06M0.24M
Acquisitions (Quarter)
0.00M
Cash from Investing Activities (Quarter)
-0.22M-0.37M-0.15M-0.13M-4.27M-1.86M-99.39M-22.25M6.57M10.23M-18.50M0.00M-0.01M26.66M15.82M15.30M11.47M16.26M
Financing Activities
Other financing activities (Quarter)
0.40M0.33M1.72M0.05M
Cash from Financing Activities (Quarter)
151.53M-0.68M-1.71M154.90M0.18M0.00M0.01M-0.17M-0.03M57.51M0.11M1.66M0.05M-0.01M0.67M
Additional items
Change in Cash (Quarter)
132.58M1.81M-9.00M142.73M-27.65M-23.84M-24.82M-19.25M-126.23M-27.16M-11.18M-5.05M18.30M-2.89M-13.02M7.42M-6.71M-2.03M-1.81M6.50M
Free Cash Flow (Quarter)
-18.90M2.49M-7.29M-12.17M-27.82M-23.84M-21.64M-20.51M-31.25M-13.29M-17.64M-15.25M-20.95M-3.01M-14.66M-19.29M-22.54M-17.26M-13.28M-10.43M
Net Cash Flow (Quarter)
132.58M1.81M-9.00M142.73M-27.65M-23.84M-24.82M-19.25M-126.23M-33.29M-11.18M-5.05M18.30M-2.89M-13.02M7.42M-6.71M-1.96M-1.81M6.50M